Redwood Pharma AB
Redwood Pharma AB engages in the development of ophthalmic drugs for medical needs in Sweden. Its lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women; and RP501, a next generation smart hydrogel medical device for the treatment of mild dry eye. The company was founded in 2012 and is headquartered in Stockholm, Sweden.
Redwood Pharma AB (REDW) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2024: -0.340x
Based on the latest financial reports, Redwood Pharma AB (REDW) has a cash flow conversion efficiency ratio of -0.340x as of March 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-3.46 Million) by net assets (Skr10.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Redwood Pharma AB - Cash Flow Conversion Efficiency Trend (2015–2023)
This chart illustrates how Redwood Pharma AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Redwood Pharma AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Redwood Pharma AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NATIONAL AUSTRAL BK
MU:NAL
|
N/A |
|
STATOIL
MU:DNQ
|
0.159x |
|
Synel M.L.L Payway Ltd
TA:SNEL
|
0.018x |
|
Trendline
TA:TREN
|
0.069x |
|
MICHELIN NOM. EO -50
F:MCHA
|
N/A |
|
ARK Venture Fund
NMFQS:ARKVX
|
N/A |
|
OSAKA GAS
BE:OSA
|
N/A |
|
DOUGLAS DYNAMICS
BE:5D4
|
-0.054x |
Annual Cash Flow Conversion Efficiency for Redwood Pharma AB (2015–2023)
The table below shows the annual cash flow conversion efficiency of Redwood Pharma AB from 2015 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | Skr13.58 Million | Skr-15.50 Million | -1.141x | -11.15% |
| 2022-12-31 | Skr15.30 Million | Skr-15.71 Million | -1.026x | +24.00% |
| 2021-12-31 | Skr15.89 Million | Skr-21.47 Million | -1.351x | +13.15% |
| 2020-12-31 | Skr7.08 Million | Skr-11.01 Million | -1.555x | -7.75% |
| 2019-12-31 | Skr12.15 Million | Skr-17.54 Million | -1.443x | -15.77% |
| 2018-12-31 | Skr12.90 Million | Skr-16.09 Million | -1.247x | +76.59% |
| 2017-12-31 | Skr2.83 Million | Skr-15.08 Million | -5.324x | -743.11% |
| 2016-12-31 | Skr11.71 Million | Skr-7.40 Million | -0.632x | +76.86% |
| 2015-12-31 | Skr-84.87K | Skr231.65K | -2.730x | -- |